Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27,712,115
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
13,703,868
-
Shares change
-
-61,365
-
Total reported value, excl. options
-
$327,947,635
-
Value change
-
-$2,477,474
-
Number of buys
-
32
-
Number of sells
-
-19
-
Price
-
$23.93
Significant Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) as of Q2 2017
59 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, $0.01 par value as of Q2 2017.
ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,703,868 shares
of 27,712,115 outstanding shares and own 49.45% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (3,688,448 shares), Novo Holdings A/S (3,033,504 shares), BVF INC/IL (1,659,200 shares), PERCEPTIVE ADVISORS LLC (952,269 shares), Cormorant Asset Management, LLC (799,469 shares), DEERFIELD MANAGEMENT CO (552,859 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (531,676 shares), BlackRock Inc. (302,156 shares), FRANKLIN RESOURCES INC (279,200 shares), and Artal Group S.A. (250,000 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.